A:While patients have reported dangerous Actos side effects for years, the global case against pioglitazone has gathered steam in the past few months. The media attention and increased FDA concern is bad for Takeda’s business, and the pressure may force them to choose between a recall and losing their company.
A few recent events that could signal an Actos recall:
- Increased FDA warning : In August, the FDA added weight to their black box warning, stating in bold language the dangers of bladder cancer for Actos patients.
- European bans : Both Germany and France banned use of Actos this summer. The European Medicines Agency continues an investigative study against Actos, possibly leading to a ban across the continent.
- Stock falling : After the European decision to discontinue use, Takeda saw a huge stock market drop in relation to its biggest seller, suggesting faith in the product had gotten even shakier.
Actos may stay on the market for the time being, but that doesn’t mean you have to suffer for the damage it has done. If you or someone you love has suffered serious side effects while taking Actos in West Palm Beach, Contact Fetterman & Associates office or Call at 561-845-2510 today.